Direct-to-Consumer advertising of pharmaceuticals as a matter of corporate social responsibility?

15Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European Union (EU). Doing so results in an alternative analysis of the struggle between proponents and opponents of DTCA from a CSR perspective, adding an alternative view on this debate. © 2009 Springer Science+Business Media B.V.

Cite

CITATION STYLE

APA

van de Pol, P. K. C., & de Bakker, F. G. A. (2010). Direct-to-Consumer advertising of pharmaceuticals as a matter of corporate social responsibility? Journal of Business Ethics, 94(2), 211–224. https://doi.org/10.1007/s10551-009-0257-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free